NCT02589860 2022-01-10
Analysis of Oral Mucositis in Patient's Undergoing Melphalan Conditioning and Autologous Stem Cell Transplant
Indiana University
Withdrawn
Clinical Trials
3 trialsNCT01402687 2013-07-16
SNP-Based Prediction of Oral Mucositis Risk in Patients Receiving Hematopoietic Stem Cell Transplants (HSCT)
Dana-Farber Cancer Institute
Completed
NCT00602147 2013-03-14
Studying Common Genetic Mutations Related to Mucositis in Patients With Multiple Myeloma Receiving High-Dose Melphalan
Vanderbilt-Ingram Cancer Center
Terminated